Standard pre‑examination protocol – must be demonstrated:
Action: Introduce yourself, explain the examination, and obtain verbal consent.
Key observations:
Systematic motor exam for myotonia:
Systematic examination:
Assess:
📋 Case Presentation – (fill in during exam)
This is a _____-year-old _____ child, referred for _____ (difficulty releasing grip / stiff muscles / muscle stiffness). On examination, the child appears _____ (well/unwell), with _____ (myopathic facies / muscle hypertrophy / wasting). Myotonia: grip myotonia _____ (present/absent), percussion myotonia _____ (present/absent), warm‑up phenomenon _____ (present/absent). Muscle strength: _____ (normal / reduced), reflexes _____ (normal / reduced). Eye findings: cataracts _____ (present/absent), ptosis _____ (present/absent). Growth: weight _____ percentile, height _____ percentile. Associated signs: _____ (frontal balding, testicular atrophy, cardiac arrhythmias).
• Myotonic Dystrophy Type 1 (DM1) – CTG repeat, multisystem.
• Myotonic Dystrophy Type 2 (DM2) – CCTG repeat, proximal weakness.
• Myotonia Congenita (Thomsen) – chloride channel (CLCN1), AD, muscle hypertrophy.
• Myotonia Congenita (Becker) – chloride channel (CLCN1), AR, muscle hypertrophy.
• Paramyotonia Congenita – sodium channel (SCN4A), cold‑induced, paradoxical myotonia.
• Sodium Channel Myotonia – SCN4A, warm‑up, no cold sensitivity.
• Schwartz‑Jampel syndrome – myotonia, chondrodysplasia, blepharophimosis.
• Brody disease – exercise‑induced stiffness (no electrical myotonia).
• Hyperkalemic periodic paralysis – myotonia, episodic weakness.
• Drug‑induced myotonia – statins, chloroquine, colchicine.
• Myotonia in hypothyroidism – rare.
• Isaacs syndrome (neuromyotonia) – continuous muscle activity (not true myotonia).
• EMG – myotonic discharges (dive‑bomber sound) – diagnostic.
• Genetic testing – DMPK (DM1), CNBP (DM2), CLCN1, SCN4A.
• CK – normal or mildly elevated.
• Muscle biopsy – may show myopathic changes, type 1 fiber atrophy (DM1).
• Genetic testing – confirmatory for specific myotonic disorders.
• Family history – AD inheritance (DM1, DM2, Thomsen).
• ECG – cardiac conduction defects (DM1).
• Ophthalmology – cataracts (DM1).
• Endocrine – glucose tolerance, thyroid (DM1).
• Parental examination – to identify affected parent (especially DM1).
• EMG – differentiates myotonia from myopathy/neuropathy.
• CK – elevated in myopathies, normal in most myotonias.
• Thyroid function – hypothyroidism (rare myotonia).
• ECG – arrhythmias (DM1).
• Genetic testing – to differentiate subtypes.
• Muscle biopsy – if diagnosis unclear.
• ECG / Holter – cardiac conduction defects (DM1).
• Pulmonary function tests – respiratory muscle weakness (DM1).
• Ophthalmology – cataracts (DM1).
• Endocrine – diabetes, hypothyroidism (DM1).
• Swallow study – dysphagia (DM1).
• Cognitive assessment – intellectual disability (DM1).
🔹 Management – Across Organ Systems
Symptomatic: mexiletine (sodium channel blocker) – reduces myotonia. Carbamazepine, phenytoin (alternative).
DM1: regular ECG/Holter (conduction defects, arrhythmias). Pacemaker if indicated.
DM1: pulmonary function tests; N‑IV if respiratory failure.
Cataracts: surgery if visually significant.
Diabetes: screening and management. Hypothyroidism: thyroid replacement.
Physiotherapy, OT – maintain function, prevent falls.
AD inheritance (DM1, DM2, Thomsen). Prenatal diagnosis, genetic testing for at‑risk relatives.
Support groups, counselling, educational support (learning difficulties).
📈 Prognosis
📋 Follow‑up Schedule